Congress Moves to Secure Synthetic DNA Through Screening and Export Controls

Legislative efforts are tightening oversight of the synthetic biology industry by mandating pathogen screening for DNA orders and restricting the export of digital genetic designs. These measures aim to bolster national biosecurity through heavy fines and federal funding restrictions.